Atıf Formatları
FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. TOYLU Et Al. , "FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk," 29. European Congress of Pathology , Amsterdam, Netherlands, 2017

TOYLU, A. Et Al. 2017. FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk. 29. European Congress of Pathology , (Amsterdam, Netherlands).

TOYLU, A., KARAÜZÜM, S., AKKAYA, B., SALİM, O., & ÜNDAR, L., (2017). FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk . 29. European Congress of Pathology, Amsterdam, Netherlands

TOYLU, ASLI Et Al. "FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk," 29. European Congress of Pathology, Amsterdam, Netherlands, 2017

TOYLU, ASLI Et Al. "FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk." 29. European Congress of Pathology , Amsterdam, Netherlands, 2017

TOYLU, A. Et Al. (2017) . "FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk." 29. European Congress of Pathology , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={ASLI TOYLU Et Al. }, title={FLT3-ITD and NPM1 mutations in acute myeloid leukemia patients with cytogenetically favorable – or intermediate- risk}, congress name={29. European Congress of Pathology}, city={Amsterdam}, country={Netherlands}, year={2017}}